What Smoore Technology Indonesia does

Smoore International Holdings Limited (HKEX: 06969.HK) is a Shenzhen-headquartered, globally dominant electronic atomization technology company founded in 2009. It designs and manufactures atomization hardware spanning ceramic heating (FEELM), electromagnetic solid-state atomization (METEX), and leak-proof architectures, holding 6,816 patent applications as of June 2023 with 1,400+ R&D experts including 100+ PhDs. The company operates a 7,200-UPH fully automated atomizer production line — the world's highest — and holds 16.5% global market share as the largest e-vapor device manufacturer.

The company generates revenue through three business models: (1) B2B ODM/OEM manufacturing of closed-system e-vapor devices, heat-not-burn components, and special-purpose atomization products for global tobacco majors including Imperial Tobacco and PMI, plus independent e-vapor brands; (2) own-brand consumer sales through VAPORESSO (40 million+ users, 40,000+ retail stores across 50+ countries), FEELM, and MOYAL — a skincare atomization brand launched in the US in October 2024 via DTC e-commerce; (3) R&D services leveraging its atomization platform for external clients including pharmaceutical partners such as AIM Immuno Tech for inhaled Ampligen drug delivery. Customers span global tobacco companies, independent e-vapor brands, pharmaceutical companies, and premium skincare consumers, with pricing negotiated bilaterally in B2B and through direct retail in B2C.

The company is incorporated in Hong Kong, with primary operating entity Smoore Technology (Shenzhen) Co., Ltd., and maintains a regional presence via a London European representative office. Smoore Technology Indonesia, with 604 employees in Malang, Jawa Timur, appears to operate as a regional subsidiary supporting manufacturing or sales within the group's global footprint. The parent group became the first e-vapor company to have science-based carbon targets validated by SBTi in June 2025.

Name

Smoore Technology Indonesia

Legal name

思摩尔国际控股有限公司

Website

https://smooreholdings.com

Company type

Public

Founded year

2009

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Smoore International (06969.HK) is a Shenzhen-based global atomization technology platform serving tobacco OEMs, consumer vaping brands, pharmaceutical partners, and skincare consumers through B2B manufacturing, own-brand retail, and R&D services.

Ownership category

akta.pro rank

Headquarters

HQ city

Shenzhen

HQ country

China

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. B2B Manufacturing (ODM/OEM): Research, design and manufacture of closed-system electronic atomization products, heat-not-burn products, and special-purpose atomization product components for global leading tobacco companies (including Imperial Brands and PMI), independent e-vapor companies and other enterprise clients.
2. Own Brand Consumer Sales: Research, design, manufacture and sale of proprietary brand electronic atomization products (VAPORESSO, FEELM) and atomization beauty products (MOYAL) to retail consumers through direct-to-consumer e-commerce and global retail networks.
3. R&D Services: Research and development services based on atomization technology reserves provided to external clients, including medical/pharmaceutical applications.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Core offering

Smoore designs, develops and manufactures electronic atomization devices across three business segments: (1) B2B ODM/OEM production of closed-system e-vapor products, heat-not-burn devices and atomization components for global tobacco companies and independent e-vapor brands; (2) own-brand consumer hardware sold under VAPORESSO, FEELM, METEX and MOYAL labels; and (3) R&D services licensing its atomization technology platform to pharmaceutical partners for inhaled drug delivery.

Product overview

SMOORE is a global atomization technology solutions provider operating through three main business segments: Atomization Transmission (electronic atomization devices through FEELM and VAPORESSO brands), Atomization Medical, and Atomization Beauty. The company's product portfolio includes FEELM (ceramic-based closed electronic atomization technology brand), VAPORESSO (high-end consumer brand), METEX (solid atomization technology), and MOYAL (skincare atomization brand). SMOORE provides both B2B manufacturing services for global tobacco companies and B2C branded products to consumers worldwide.

Differentiator

Problem solved

Functional benefit

Brands

• FEELM: High-end vaporization technology brand based on global ceramic heating technology, combining taste restoration technology and innovative electronic technology for high-quality closed electronic vaporization solutions
• VAPORESSO
• METEX
• MOYAL

Products and services

• FEELM FEELM is Smoore's high-end ceramic-heating atomization technology brand, combining flavor restoration technology and innovative electronics to deliver high-quality closed-system e-vapor solutions. It is sold B2B to global tobacco and e-vapor companies and licensed across 50+ countries.
• VAPORESSO VAPORESSO is Smoore's owned consumer vaping hardware brand, selling pod systems, open-system devices and disposable products through 40,000+ certified retail stores and brand channels to 40M+ global users. Products carry CRC Canada, TPD Europe and KC Korea certifications.
• METEX METEX is Smoore's solid-state atomization technology brand, providing technology and product solutions for different solid atomization media based on resistive and electromagnetic heating platforms with precise temperature control.
• MOYAL MOYAL is Smoore's premium skincare atomization brand, using patented two-phase gas-liquid atomization technology to convert serums into microparticles for deeper transdermal delivery. Sold direct-to-consumer in the US via www.MoyalBeauty.com as the Lanshi Superconducting Gun device plus matched serums.
• Inhalation Drug Delivery Device Platform Smoore provides R&D services and co-development of self-administered aerosolized drug delivery devices for pharmaceutical partners, leveraging its atomization technology platform. The flagship engagement is with AIM Immuno Tech for inhaled delivery of Ampligen (targeting ME/CFS and COVID-19 applications).

Quantifiable outcome

• 16.5% global market share as world's largest e-vapor device manufacturer
• +5 more outcomes

Named customers3 records

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• AIM Immuno Tech (NYSE: AIM)coreStrategic or Co-development Partner · 6 April 2020Smoore International signed a material transfer and research agreement with AIM Immuno Tech on April 6, 2020, to develop an inhaled drug delivery device using Smoore's aerosol inhalation technology for AIM's Ampligen drug. Ampligen has received approval in Argentina for ME/CFS and completed Phase 3 clinical trials in the US. The partnership targets COVID-19 treatment applications and aligns with Smoore's strategy to expand into the medical/pharmaceutical sector. AIM's Chief Science Officer Dr. David Strayer noted the goal of developing a self-administered inhaled device that can safely deliver aerosolized Ampligen deep into lung airways.

Scale indicators12 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• NJOY: NJOY is a US-focused vaping device competitor that has received FDA marketing authorization for e-vapor products, positioning it as a direct competitor in regulated markets and a comparable hardware-focused player.
• Innokin Technology: Innokin is a competing vaping device manufacturer with comparable product categories (open and closed systems) targeting similar consumer and OEM markets globally, representing direct competition in the hardware category.
• RELX Technology: RELX is one of the largest closed-system e-vapor companies globally and Smoore's most direct competitor in the vaping device category, with comparable target customers, technology platform, and Asia-centric footprint.

Emerging players

• AptarGroup: Aptar is a leader in drug delivery devices including inhalation platforms; relevant as an adjacent competitor and potential partner for Smoore's emerging medical atomization business (e.g., AIM Immuno Tech collaboration).

Broad incumbents

• Philip Morris International: PMI is both a named strategic customer of Smoore for closed-system e-vapor and a competitor through its IQOS heat-not-burn platform — a major global tobacco incumbent with vertically integrated RRP investments.
• Imperial Brands: Imperial Brands is a named key B2B customer of Smoore and a major global tobacco company also developing its own RRP portfolio — overlapping customer/supplier dynamic similar to PMI.
• British American Tobacco: BAT is a major global tobacco incumbent with competing RRP products including Vuse (e-vapor) and Glo (heat-not-burn), positioning it as both a potential customer and a competitor to Smoore in the reduced-risk product category.
• Altria Group: Altria is a major US tobacco incumbent and competitor in the RRP space through its NJOY investment and on! nicotine pouches — with potential to source from or compete with Smoore for OEM/ODM partnerships.
• Japan Tobacco International: JT International is a major global tobacco incumbent with Ploom heat-not-burn products — both a potential B2B customer for Smoore's atomization manufacturing and a competitor in the RRP category across Asian and European markets.

Others

• West Pharmaceutical Services: West Pharmaceutical provides drug delivery components and containment solutions — an adjacent player relevant to Smoore's emerging medical inhalation drug delivery business and a potential ecosystem participant.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat7 records

Key risks4 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/smoore-technology-indonesia

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Smoore Technology Indonesia